semaglutide plus levocarnitine + L-Carnitine Boost GLP-1 Tolerance and Weight-Loss

Tirzepatide (Mounjaro, Zepbound) is an FDA-approved dual GIP/GLP-1 receptor agonist used for type 2 diabetes and chronic weight management

As a result, even with proper dosing, blood sugar may fluctuate more than expected

The monitoring protocol is well-established because the drug has been in clinical use for years

Wegovy dosing schedule: Weeks 1-4: Starting dose 0.25 mg once weekly Weeks 5-8: 0.5 mg once weekly Weeks 9-12: 1 mg once weekly Weeks 13-16: 1.7 mg once weekly Weeks 17+: 1.7 or 2.4 mg once weekly The recommended maintenance dose of Wegovy in adults is 1.7 or 2.4 mg once weekly

He noted that some also opt for brow and upper eye lifts, though less often, as those areas are less prone to the negative effects of rapid fat loss

Some patients prefer daily injections as they feel more in control of their treatment regimen